IN the present study we investigated the role of the cholinergic pathw
ay in phosphoinositide metabolism activation observed during soman-ind
uced convulsions. We thus studied the effect of atropine sulphate, a m
uscarinic antagonist (20 mg kg-1, ip.), on IP3 levels in rat hippocamp
us. We demonstrated that initially, the increase of IP3 is closely sei
zure-related. On the other hand, after 10 min of seizures, the IP3 enh
ancement and the seizure activity are no longer correlated. After 20 m
in of seizures, atropine failed to inhibit soman-induced IP3 enhanceme
nt, suggesting that the activation of another neurotransmitter system(
s) linked to PPI turnover succeeds the cholinergic stimulation.